ethyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR) and 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45), as referred to in Council Implementing Decision (EU) 2015/1873 [6].
eitil-5-(4-meitilfeinil)-4,5-dé-hiodrocsasóil-2-aimín (4,4′-DMAR) agus 1-cioglaiheicsil-4-(1,2-défeinileitil)pipioraisín (MT-45), dá dtagraítear i gCinneadh Cur Chun Feidhme (AE) 2015/1873 ón gComhairle [6].